Why the study?
Does cilazapril improve small artery remodeling and function compared to atenolol in patients with essential hypertension?
Does cilazapril improve small artery remodeling and function compared to atenolol in patients with essential hypertension?
Treatment with the ACE inhibitor cilazapril, but not the beta-blocker atenolol, corrects small artery remodeling and endothelial dysfunction in patients with essential hypertension.
No takes yet. Share an insight, caveat, or question.
Supports cilazapril over atenolol for reversing small artery remodeling; confirms ACE inhibitor advantages on vascular structure in hypertension.
Ernesto L. Schiffrin (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: